Lilly blows past revenue benchmarks, again raises full-year outlooknews2025-10-30T11:09:02+00:00October 30th, 2025|Endpoints News|
Novo Nordisk proposes to acquire Metsera in bid to disrupt Pfizer’s dealnews2025-10-30T10:16:25+00:00October 30th, 2025|Endpoints News|
Tubulis upsizes Series C to $401M to ‘push the boundaries of ADCs’news2025-10-30T10:00:43+00:00October 30th, 2025|Endpoints News|
Roche promises $1B to China biotech for preclinical COPD bispecificnews2025-10-30T01:48:30+00:00October 30th, 2025|Endpoints News|
BIO chief to senators: China could pass US within two yearsnews2025-10-29T18:51:36+00:00October 29th, 2025|Endpoints News|
Thermo Fisher to buy data solutions-focused Clario for up to $9.4Bnews2025-10-29T18:49:39+00:00October 29th, 2025|Endpoints News|
GSK confirms it has completed IRA negotiations ahead of CMS deadlinenews2025-10-29T17:54:46+00:00October 29th, 2025|Endpoints News|
Lilly budgets $1.2B for GLP-1 pill factory in Puerto Rico news2025-10-29T17:38:18+00:00October 29th, 2025|Endpoints News|
Ventus stops Phase 2 of NLRP3 inhibitor that was being tested in Parkinson’snews2025-10-29T17:05:59+00:00October 29th, 2025|Endpoints News|
FDA to reduce regulatory red tape for biosimilarsnews2025-10-29T16:43:48+00:00October 29th, 2025|Endpoints News|
